Blogs

Survivorship Benefits of Proton Therapy
by OncoLink Editorial Team
June 17, 2015

Don't Assume You Understand
by Bob Riter
July 29, 2015

Related News

Sarcoma Characteristics ID'd in TP53 Mutation Carriers

Aug 22, 2011

Rhabdomyosarcoma likely <5 years, osteosarcoma at any age, leiomyosarcoma >20 years


Cixutumumab Tolerated for Pediatric Refractory Solid Tumors

Dec 22, 2011

Recommended phase II pediatric dose is 9 mg/kg intravenously once per week


Receptor in Osteosarcoma May Provide Treatment Approach

Jul 30, 2015

Interleukin-11 receptor alpha is highly expressed in primary osteosarcoma and lung metastases